Photo #6262001
You need to pass authentication to download files
A worker scans the barcode on the Avifavir antiviral drug approved to treat patients suffering from the coronavirus, at a storage facility at the unknown location, Russia. The Russian Direct Investment Fund (RDIF) and the ChemRar pharmaceutical company said on June 11 they started delivering Avifavir medication against COVID-19 to hospitals across the country. Avifavir, created on the basis of Favipiravir, is one of the two drugs for COVID-19 treatment registered globally. In early June, the Russian Health Ministry said that the medication had proven 90 percent efficient during trials.
| Categories: | Science & Technology, Health, Social Issues, Human Interest |
|---|---|
| Feature: | Russia Coronavirus Antiviral Drug |
| Location: | Russia |
| Event date: | 10.06.2020 |
| Import date: | 11.06.2020 |
| Author: | Andrey Rudakov |
| Keywords: | SARS-CoV-2, COVID, COVID-19, virus, pandemic, epidemic, infection, 2019-nCoV, coronavirus, disease |
| Source: | Russian Direct Investment Fund (RDIF) |
| Credit: | Sputnik |
| Original: | Digital |
| Content language: | English |
| Job-ID: | 6004cdf21f8b347f |